Conclusion
Compared with placebo, oral GKAs alone or combined with metformin seems to be effective and relatively safe in the treatment of T2DM, which indicates that oral GKAs can be considered as a monotherapy or a combination therapy with metformin for T2DM patients. Further clinical studies are warranted to explore the long-term efficacy and safety of GKAs.